275 related articles for article (PubMed ID: 20878588)
21. Particulate delivery systems for animal vaccines.
Scheerlinck JP; Greenwood DL
Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
[TBL] [Abstract][Full Text] [Related]
22. Laser vaccine adjuvants. History, progress, and potential.
Kashiwagi S; Brauns T; Gelfand J; Poznansky MC
Hum Vaccin Immunother; 2014; 10(7):1892-907. PubMed ID: 25424797
[TBL] [Abstract][Full Text] [Related]
23. A need for effective adjuvants.
Bunce CJ; Morse MA
Curr Opin Mol Ther; 2003 Feb; 5(1):8-9. PubMed ID: 12669464
[No Abstract] [Full Text] [Related]
24. Adjuvants and delivery systems for antifungal vaccines: current state and future developments.
Portuondo DL; Ferreira LS; Urbaczek AC; Batista-Duharte A; Carlos IZ
Med Mycol; 2015 Jan; 53(1):69-89. PubMed ID: 25362733
[TBL] [Abstract][Full Text] [Related]
25. Carbohydrate-based vaccine adjuvants - discovery and development.
Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J
Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693
[TBL] [Abstract][Full Text] [Related]
26. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
27. Gaps in knowledge and prospects for research of adjuvanted vaccines.
Seder R; Reed SG; O'Hagan D; Malyala P; D'Oro U; Laera D; Abrignani S; Cerundolo V; Steinman L; Bertholet S
Vaccine; 2015 Jun; 33 Suppl 2():B40-3. PubMed ID: 26022566
[TBL] [Abstract][Full Text] [Related]
28. Innovations in vaccine development: can regulatory authorities keep up?
Cox MM; Onraedt A
Expert Rev Vaccines; 2012 Oct; 11(10):1171-3. PubMed ID: 23176649
[TBL] [Abstract][Full Text] [Related]
29. Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.
Garçon N; Van Mechelen M
Expert Rev Vaccines; 2011 Apr; 10(4):471-86. PubMed ID: 21506645
[TBL] [Abstract][Full Text] [Related]
30. Delivery technologies for human vaccines.
Moingeon P; de Taisne C; Almond J
Br Med Bull; 2002; 62(1):29-44. PubMed ID: 12176848
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory biomaterials.
Mallapragada SK; Narasimhan B
Int J Pharm; 2008 Dec; 364(2):265-71. PubMed ID: 18662761
[TBL] [Abstract][Full Text] [Related]
32. Gene Based Vaccines: Optimising Development and Delivery - A marcus evans Conference.
Garren H
IDrugs; 2010 Nov; 13(11):759-61. PubMed ID: 21046520
[TBL] [Abstract][Full Text] [Related]
33. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
34. ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.
Drane D; Gittleson C; Boyle J; Maraskovsky E
Expert Rev Vaccines; 2007 Oct; 6(5):761-72. PubMed ID: 17931156
[TBL] [Abstract][Full Text] [Related]
35. Saponin-adjuvanted particulate vaccines for clinical use.
Skene CD; Sutton P
Methods; 2006 Sep; 40(1):53-9. PubMed ID: 16997713
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in vaccine delivery.
Cordeiro AS; Alonso MJ
Pharm Pat Anal; 2016; 5(1):49-73. PubMed ID: 26667309
[TBL] [Abstract][Full Text] [Related]
37. New horizons in adjuvants for vaccine development.
Reed SG; Bertholet S; Coler RN; Friede M
Trends Immunol; 2009 Jan; 30(1):23-32. PubMed ID: 19059004
[TBL] [Abstract][Full Text] [Related]
38. Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.
Maraskovsky E; Schnurr M; Wilson NS; Robson NC; Boyle J; Drane D
Immunol Cell Biol; 2009 Jul; 87(5):371-6. PubMed ID: 19381160
[TBL] [Abstract][Full Text] [Related]
39. PepTalk--CHI's Ninth Annual Meeting--Engineering Protein & Peptide Therapeutics: Peptides.
Craik D
IDrugs; 2010 Mar; 13(3):156-8. PubMed ID: 20191429
[TBL] [Abstract][Full Text] [Related]
40. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]